Growth Metrics

Kraig Biocraft Laboratories (KBLB) Accumulated Expenses (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Accumulated Expenses for 11 consecutive years, with $65292.0 as the latest value for Q3 2022.

  • Quarterly Accumulated Expenses changed 0.0% to $65292.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $65292.0 through Sep 2022, changed 0.0% year-over-year, with the annual reading at $31657.0 for FY2021, N/A changed from the prior year.
  • Accumulated Expenses hit $65292.0 in Q3 2022 for Kraig Biocraft Laboratories, roughly flat from $65292.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.9 million in Q3 2019 to a low of $29943.0 in Q2 2021.
  • Historically, Accumulated Expenses has averaged $1.0 million across 4 years, with a median of $65292.0 in 2018.
  • Biggest YoY gain for Accumulated Expenses was 4680.37% in 2018; the steepest drop was 97.1% in 2018.
  • Year by year, Accumulated Expenses stood at $65292.0 in 2018, then soared by 5859.39% to $3.9 million in 2019, then crashed by 99.19% to $31657.0 in 2021, then soared by 106.25% to $65292.0 in 2022.
  • Business Quant data shows Accumulated Expenses for KBLB at $65292.0 in Q3 2022, $65292.0 in Q2 2022, and $65292.0 in Q1 2022.